<DOC>
	<DOCNO>NCT01695317</DOCNO>
	<brief_summary>Traditionally , beta blocker use migraine prophylaxis , later year also antiepileptic drug . Contraindications side effect degree limit use , new prophylactic use migraine sufferer little side effect demand . One product may seem fulfill requirement Acetyl-L-carnitine , dietary supplement naturally occur plant animal . L-carnitine necessary fatty-acid metabolism energy production . To knowledge , placebo-controlled study previously evaluate efficacy Acetyl-L-carnitine adult migraine . The aims present study evaluate efficacy Acetyl-L-carnitine prophylaxis migraine patient</brief_summary>
	<brief_title>Effect Acetyl-L-carnitine Migraine</brief_title>
	<detailed_description>The study single-centre double-blinded , randomize , placebo control crossover study Acetyl-L-carnitine placebo . We plan include 72 patient . The follow duration 36 week . The study perform accord Good Clinical Practice , rely partly International Headache Society Guidelines control trial drug migraine 2012 partly guideline divulge IHS task force trial guideline chronic migraine . After screen visit include neurological consultation , eligible patient sign inform consent declaration enter 4 week run-in ( baseline ) period keep headache diary . After 4 week return second visit . If 2 migraine attack allow proceed study . If less 2 migraine attack ( require proceeding study ) , allow extend baseline period another 4 week . Those whole 8 week period average 2 migraine attack per month also allow proceed . Otherwise exclude study . Details treatment period The duration two treatment period 12 week . During period one telephone contact start treatment period remind patient start medicine , one 2 week check compliance side effect . In second last week every treatment period doctor nurse visit drug account dispense new medicine next period . At visit one ensure patient enough medicine leave finish period wash-out . As recommended crossover study , participant enter washout period 4 week two treatment period , reduce risk carryover effect . Randomization Randomization generate use computerized procedure . A randomization list contain 72 patient number make start study , patient number indicated package medicine patient . The study crossover design , two different treatment period ( active placebo ) arise two different treatment sequence ( AP PA ) . Patients therefore randomize block 4 one two treatment sequence assign patient random order . With 72 patient include , mean 18 patient randomized block . In block , 50 % patient treatment sequence AP , 50 % PA random order .</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Acetylcarnitine</mesh_term>
	<criteria>Age 18 65 year Signed informed consent Migraine without aura accord ICHD2 criterion chronic migraine accord ICHD2 criterion ( revision 1 ) Retrospectively 2 migraine attack per month last 3 month During baseline period 2 migraine attack Debut migraine least one year prior inclusion Start migraine age 50 year BMI 1835 kg/m2 No medication overuse last 3 month define headache &gt; 14 days/month combine overuse simple analgesic &gt; 14 days/month triptans combine medication ≥ 10 days/month . Interval headache distinguishable migraine Chronic tensiontype headache headache migraine occur ≥ 15 days/month without medication overuse Pregnancy , nurse inability use contraceptives Hypersensitivity active substance History angioneurotic edema , diabetes mellitus , significant psychiatric illness and/or HADS anxiety score ≥ 11 HADS depression score ≥ 11 , and/or use SSRI , antipsychotic medication , antidepressant medication last 3 month Use daily migraine prophylactic less 3 month prior start study Previous use AcetylLcarnitine BMI &lt; 18 kg/m2 BMI &gt; 35 kg/m2 Having try ≥ 3 prophylactic drug migraine last 5 year Subjects require detoxification acute medication Patients consistently fail respond acute migraine medication Patients alcohol illicit drug dependence ; 13 ) Subjects renal disease decrease renal function Previous present history asthma vascular disease , arterial claudication include .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Migraine</keyword>
	<keyword>Preventive medication</keyword>
</DOC>